Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: Role of TNF-α and IGF-II

Endocrinology

Volumn 154, Issue 7, 2013, Pages 2352-2364

  Gómez Hernández, Almudena ^a   Escribano, Óscar ^a   Perdomo, Liliana ^a   Otero, Yolanda F ^a   García Gómez, Gema ^a   Fernández, Silvia ^a   Beneit, Nuria ^a   Benito, Manuel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; THROMBOXANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879302387     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2161     Document Type: Article

References (45)

1. Myers MG Jr, White MF. Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol. 1996;36:615-658. (Pubitemid 26168711)
2. Kennedy SG, Wagner AJ, Conzen SD, et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997;11:701-713. (Pubitemid 27157159)
3. Seino S, Bell GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun. 1989;159:312-316. (Pubitemid 19087646)
4. Moller DE, Yokota A, Caro JF, Flier JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol. 1989;3:1263-1269. (Pubitemid 19210437)
5. Goldstein BJ, Dudley AL. The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol Endocrinol. 1990;4:235-244.
6. Frasca F, Pandini G, Scalia P, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999;19:3278-3288. (Pubitemid 29193789)
7. Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des. 2007;13:671-686. (Pubitemid 46510744)
8. Vogt B, Carrascosa JM, Ermel B, Ullrich A, Häring HU. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun. 1991;177:1013-1018.
9. Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M. β-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform. Diabetes. 2009;58:820-828.
10. Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R, Baserga R. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology. 2003;144:2650-2658. (Pubitemid 36629918)
11. Kosaki A, Webster NJ. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J Biol Chem. 1993;268:21990-21996. (Pubitemid 23320706)
12. Nevado C, Benito M, Valverde AM. Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes. Mol Biol Cell. 2008;19:1185-1198. (Pubitemid 351481830)
13. Gómez-Hernández A, Otero YF, de las Heras N, et al. Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction. Endocrinology. 2012;153:1242-1255.
14. Guerra C, Navarro P, Valverde AM, et al. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest. 2001;108:1205-1213. (Pubitemid 32995379)
15. López-Franco O, Hernández-Vargas P, Ortiz-Muñoz G, et al. Parthenolide modulates the NF-κB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:1864-1870. (Pubitemid 44305342)
16. Hernández-Presa M, Bustos C, Ortego M, et al. Angiotensin- converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95:1532-1541. (Pubitemid 27142812)
17. Zaina S, Pettersson L, Ahrén B, et al. Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem. 2002;277:4505-4511. (Pubitemid 34968718)
18. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809. (Pubitemid 23132154)
19. Ross R. Cellular and molecular studies of atherogenesis. Atherosclerosis. 1997;131(Suppl l):S3-S4. (Pubitemid 27306749)
20. Schwartz SM. The intima: a new soil. Circ Res. 1999;85:877-879.
21. Faries PL, Rohan DI, Takahara H, et al. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg. 2001;33:601-607. (Pubitemid 32215612)
22. Hsueh WA, Jackson S, Law RE. Control of vascular cell proliferation and migration by PPAR-γ: a new approach to the macrovascular complications of diabetes. Diabetes Care. 2001;24:392-397. (Pubitemid 32119143)
23. Siddle K. Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol. 2011;47:R1-R10.
24. Bartolomé A, Guillén C, BenitoM. Role of the TSC1-TSC2 complex in the integration of insulin and glucose signaling involved in pancreatic beta-cell proliferation. Endocrinology. 2010;151:3084-3094.
25. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004;286:H1597-H1602. (Pubitemid 38525443)
26. Isenovi ER, Soski S, Trpkovi A, et al. Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferation. Curr Pharm Des. 2010;16:3895-3902.
27. BreenDM,Giacca A. Effects of insulin on the vasculature. Curr Vasc Pharmacol. 2011;9:321-332.
28. Goetze S, Kintscher U, Kaneshiro K, et al. TNFα induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis. 2001;159:93-101. (Pubitemid 33016626)
29. Viedt C, Soto U, Krieger-Brauer HI, et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940-948. (Pubitemid 30207566)
30. Chen QW, Edvinsson L, Xu CB. Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. BMC Cell Biol. 2009;10:52.
31. Hafizi S, Chester AH, Allen SP, Morgan K, Yacoub MH. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron Artery Dis. 1998;9:167-175. (Pubitemid 28279488)
32. Hafizi S, Allen SP, Goodwin AT, Chester AH, Yacoub MH. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors. Atherosclerosis. 1999;146:351-359. (Pubitemid 29418067)
33. Ko FN, Yu SM, Kang YF, Teng CM. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat. Br J Pharmacol. 1995;116:1801-1808.
34. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptormRNAexpression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun. 1993;191:1081-1088. (Pubitemid 23231600)
35. Ohishi M, Dusting GJ, Fennessy PA, Mendelsohn FA, Li XC, Zhuo JL. Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries. Int J Physiol Pathophysiol Pharmacol. 2010;2:111-124.
36. Cyrus T, Ding T, Praticò D. Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition. Atherosclerosis. 2010;208:376-381.
37. Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A. 1998;95:570-575. (Pubitemid 28083784)
38. Denley A, Wallace JC, Cosgrove LJ, Forbes BE. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res. 2003;35:778-785. (Pubitemid 38058183)
39. Zhang L, Peppel K, Sivashanmugam P, et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:1087-1094. (Pubitemid 46641962)
40. Sciacca L, Costantino A, Pandini G, et al. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene. 1999;18:2471-2479. (Pubitemid 29206160)
41. Pandini G, Vigneri R, Costantino A, et al. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res. 1999;5:1935-1944. (Pubitemid 29334478)
42. Polanco JI, Albajar M, Pocoví M, Rodríguez Rey JC. Induction of insulin-like growth factor receptor (IGF IR) mRNA levels by low density lipoproteins. Biochem Biophys Res Commun. 1996;226:917-922. (Pubitemid 26348569)
43. von der Thüsen JH, Borensztajn KS, Moimas S, et al. IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype. Am J Pathol. 2011;178:924-934.
44. Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol. 2001;33:1777-1789. (Pubitemid 32977132)
45. Engberding N, San Martín A, Martin-Garrido A, et al. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2009;29:408-415. Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III